Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Do Carpamine
2. N-(n-acetyl-l-methionyl)-o,o-bis(ethoxycarbonyl)dopamine
3. Ta 870
4. Ta-8704
1. 74639-40-0
2. Tanadopa
3. Docarpamine [inn]
4. Docarpamina
5. Ta-870
6. Rpq57d8s72
7. Dtxsid1057820
8. [4-[2-[[(2s)-2-acetamido-4-methylsulfanylbutanoyl]amino]ethyl]-2-ethoxycarbonyloxyphenyl] Ethyl Carbonate
9. (-)-(s)-2-acetamido-n-(3,4-dihydroxyphenethyl)-4-(methylthio)butyramide Bis(ethyl Carbonate) (ester)
10. Docarpaminum
11. Do Carpamine
12. Docarpaminum [inn-latin]
13. Docarpamina [inn-spanish]
14. (s)-4-(2-(2-acetamido-4-(methylthio)butanamido)ethyl)-1,2-phenylene Diethyl Dicarbonate
15. Tanadopa (tn)
16. Unii-rpq57d8s72
17. Ta-8704
18. N-(n-acetyl-l-methionyl)-o,o-bis(ethoxycarbonyl)dopamine
19. Docarpamine (jan/inn)
20. Docarpamine [mi]
21. Docarpamine [jan]
22. Docarpamine [mart.]
23. Docarpamine [who-dd]
24. Schembl219671
25. Chembl2106351
26. Dtxcid8031609
27. Schembl23356827
28. Chebi:31513
29. Tox21_113707
30. Ncgc00249931-01
31. Carbonic Acid, 4-(2-((2-(acetylamino)-4-(methylthio)-1-oxobutyl)amino)ethyl)-1,2-phenylene Diethyl Ester, (s)-
32. Cas-74639-40-0
33. Ns00127253
34. D01903
35. Q27288234
| Molecular Weight | 470.5 g/mol |
|---|---|
| Molecular Formula | C21H30N2O8S |
| XLogP3 | 2.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 16 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 155 |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 619 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Dopamine Agonists
Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)
ABOUT THIS PAGE
55
PharmaCompass offers a list of Docarpamine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Docarpamine manufacturer or Docarpamine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Docarpamine manufacturer or Docarpamine supplier.
PharmaCompass also assists you with knowing the Docarpamine API Price utilized in the formulation of products. Docarpamine API Price is not always fixed or binding as the Docarpamine Price is obtained through a variety of data sources. The Docarpamine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Docarpamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Docarpamine, including repackagers and relabelers. The FDA regulates Docarpamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Docarpamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Docarpamine supplier is an individual or a company that provides Docarpamine active pharmaceutical ingredient (API) or Docarpamine finished formulations upon request. The Docarpamine suppliers may include Docarpamine API manufacturers, exporters, distributors and traders.
Docarpamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Docarpamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Docarpamine GMP manufacturer or Docarpamine GMP API supplier for your needs.
A Docarpamine CoA (Certificate of Analysis) is a formal document that attests to Docarpamine's compliance with Docarpamine specifications and serves as a tool for batch-level quality control.
Docarpamine CoA mostly includes findings from lab analyses of a specific batch. For each Docarpamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Docarpamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Docarpamine EP), Docarpamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Docarpamine USP).
